Managing directors Hakan Goker (L) and Owen Lozman, M Ventures
Merck KGaA's venture arm is ready to make new investments, raising more than $675M to get things going
Merck KGaA’s venture capital arm has closed its latest fund, bringing the European conglomerate fresh cash to invest in up-and-coming biotechs.
M Ventures raised …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.